Replimune Group Inc (NASDAQ: REPL) on Tuesday, soared 12.00% from the previous trading day, before settling in for the closing price of $9.33. Within the past 52 weeks, REPL’s price has moved between $2.68 and $17.00.
Healthcare Sector giant saw their annual sales slid by -14.85% over the last five years. The company achieved an average annual earnings per share of 7.19%. With a float of $66.34 million, this company’s outstanding shares have now reached $77.81 million.
Replimune Group Inc (REPL) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Replimune Group Inc is 15.01%, while institutional ownership is 96.64%. The most recent insider transaction that took place on Aug 15 ’25, was worth 49,157. In this transaction Chief Financial Officer of this company sold 9,154 shares at a rate of $5.37, taking the stock ownership to the 134,368 shares. Before that another transaction happened on May 20 ’25, when Company’s Director sold 32,279 for $8.06, making the entire transaction worth $260,169. This insider now owns 1,405,071 shares in total.
Replimune Group Inc (REPL) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.68 earnings per share (EPS) for the period topping the consensus outlook (set at -0.74) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.88% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Replimune Group Inc (REPL) is currently performing well based on its current performance indicators. A quick ratio of 6.94 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Analysing the last 5-days average volume posted by the [Replimune Group Inc, REPL], we can find that recorded value of 3.76 million was lower than the volume posted last year of 4.53 million. As of the previous 9 days, the stock’s Stochastic %D was 84.22%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 73.58%, which indicates a significant decrease from 93.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.66 in the past 14 days, which was higher than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.54, while its 200-day Moving Average is $8.72. Now, the first resistance to watch is $11.11. This is followed by the second major resistance level at $11.76. The third major resistance level sits at $12.68. If the price goes on to break the first support level at $9.54, it is likely to go to the next support level at $8.62. Now, if the price goes above the second support level, the third support stands at $7.97.
Replimune Group Inc (NASDAQ: REPL) Key Stats
Market capitalization of the company is 815.68 million based on 78,056K outstanding shares. Right now, sales total 0 K and income totals -247,300 K. The company made 0 K in profit during its latest quarter, and -86,690 K in sales during its previous quarter.
